Form 8-K - Current report:
SEC Accession No. 0001555280-21-000322
Filing Date
2021-10-14
Accepted
2021-10-14 16:36:54
Documents
14
Period of Report
2021-10-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zts-20211014.htm   iXBRL 8-K 37377
2 EX-99.1 exhibit9912021q4dividend10.htm EX-99.1 11580
6 image.jpg GRAPHIC 10748
  Complete submission text file 0001555280-21-000322.txt   204359

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zts-20211014.xsd EX-101.SCH 1977
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zts-20211014_lab.xml EX-101.LAB 24270
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zts-20211014_pre.xml EX-101.PRE 12710
7 EXTRACTED XBRL INSTANCE DOCUMENT zts-20211014_htm.xml XML 10935
Mailing Address 10 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 10 SYLVAN WAY PARSIPPANY NJ 07054 973-822-7000
Zoetis Inc. (Filer) CIK: 0001555280 (see all company filings)

EIN.: 460696167 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35797 | Film No.: 211323669
SIC: 2834 Pharmaceutical Preparations